BIOMAT Database Logo BIOMAT Database Logo

A case of poorly differentiated Sertoli-Leydig tumor of the ovary. 2004

Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Kaza Medical Group, 113 Neurology Way, Milford, DE 19963, USA. elaratorre@yahoo.com

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D015746 Abdominal Pain Sensation of discomfort, distress, or agony in the abdominal region. Colicky Pain,Abdominal Pains,Colicky Pains,Pain, Abdominal,Pain, Colicky,Pains, Abdominal,Pains, Colicky
D018310 Sertoli-Leydig Cell Tumor A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS. Androblastoma,Arrhenoblastoma,Sertoli-Leydig Cell Tumors,Androblastomas,Arrhenoblastomas,Cell Tumor, Sertoli-Leydig,Cell Tumors, Sertoli-Leydig,Sertoli Leydig Cell Tumor,Sertoli Leydig Cell Tumors,Tumor, Sertoli-Leydig Cell,Tumors, Sertoli-Leydig Cell

Related Publications

Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
[Poorly differentiated Sertoli-Leydig cell tumor of the ovary: imaging with pathologic correlations. A case report].
September 2001, La Radiologia medica,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Poorly Differentiated Sertoli-Leydig Cell Tumour of Ovary with Heterologous Elements.
May 2017, Journal of clinical and diagnostic research : JCDR,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Bilateral poorly differentiated Sertoli-Leydig ovarian tumor associated with dysgerminoma: case report.
January 2013, European journal of gynaecological oncology,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Successful term pregnancies after laparoscopic excision of poorly differentiated Sertoli-Leydig cell tumor of the ovary.
July 2012, Journal of gynecologic oncology,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Ossifying well-differentiated Sertoli-Leydig cell tumor of the ovary.
February 2000, Annals of diagnostic pathology,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report.
November 2015, Gynecologic oncology reports,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms.
June 1984, The American journal of surgical pathology,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor in a 12-Month-Old Girl.
January 2020, Journal of Indian Association of Pediatric Surgeons,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Immunohistochemical and ultrastructural analysis of a poorly differentiated pediatric age Sertoli-Leydig cell tumor.
February 2007, Experimental and molecular pathology,
Eduardo Lara-Torre, and Jennifer E Dietrich, and Alan Kaplan, and Henry Lopez, and Ian Jaffee
Cytologic, immunocytologic, histopathologic and immunohistologic diagnosis of the poorly differentiated sertoli-leydig cell tumor.
January 2011, Acta cytologica,
Copied contents to your clipboard!